Current filters:

Caspofungin Acetate

1 to 9 of 24 results

Merck & Co's Cancidas gets expanded US label


US drug major Merck & Co says that the Food and Drug Administration has approved an expanded label for…

CancidasCaspofungin AcetateMerck KGaA

EMEA's PDCO issues PIP review opinions


The European Medicines Agency's (EMEA) Pediatric Committee (PDCO) has adopted opinions on pediatric investigation…

CancidasCaspofungin AcetateCozaarHyzaarLosartan PotassiumLosartan Potassium-HydrochlorothiazideMerck KGaAMontelukast SodiumPfizerSingulair

Merck & Co's Cancidas comparable to AmBisome in IFI


US drug major Merck & Co's Cancidas (caspofungin acetate) demonstrated a safety and efficacy profile…

AbelcetAmbisomeAmino AcidsAmphotericin BCancidasCaspofungin AcetateFungizoneGilead SciencesGiliad SciencesInjectionMerck KGaAPhysostigmine Salicylate

Merck & Co returns to India


US drug major Merck & Co has said that it will restart operations at its wholly-owned subsidiary MSD…

AggrastatCancidasCaspofungin AcetateErtapenem InjectionInvanzMerck KGaAPneumococcal Vaccine PolyvalentPneumovaxTirofibanVaricella Virus Vaccine LiveVarivax

Vicuron antifungal promising in Phase II


Vicuron Pharmaceuticals, born out of the merger of Versicor with Biosearch Italia (Marketletters passim),…

AbelcetAmbisomeAmphotericin BAnidulafunginCancidasCaspofungin AcetateDiflucanEraxisFluconazoleFungizoneMerck KGaA

Vicuron files NDA for anidulafungin in USA


Vicuron Pharmaceuticals of the USA, born out of the merger of Versicorwith Biosearch Italia (Marketletters…

AnidulafunginCancidasCaspofungin AcetateEraxisMerck KGaA

Indevus buys antifungal drug from Aventis


Indevus Pharmaceuticals of the USA has licensed exclusive worldwiderights from France-based Aventis to…

Aventis PharmaCancidasCaspofungin AcetateMerck KGaANystatinOral

1 to 9 of 24 results

Back to top